The Study of CM326 in Adult Subjects With Atopic Dermatitis

Inclusion Criteria: * With confirmed Atopic Dermatitis (AD) at the screening. * Have the ability to understand the nature of the study and voluntarily sign the informed consent. * Be able to communicate well with investigators and follow up protocol requirements. * The subjects agreed to use highly effective contraceptive measures during the study. Exclusion Criteria: * Not enough washing-out period for previous therapy. * Received allergen specific immunotherapy (desensitization) within 6 months prior to baseline. * Major surgery is planned during the study period. * Women who are pregnant or breastfeeding, or who plan to become pregnant during the study.